The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer | Anticancer Research
SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C | Cell Death & Disease
Therapeutic silencing of SMOC2 prevents kidney function loss in mouse model of chronic kidney disease - ScienceDirect
SMOC2 inhibits calcification of osteoprogenitor and endothelial cells | PLOS ONE
Fibroblastic SMOC2 Suppresses Mechanical Nociception by Inhibiting Coupled Activation of Primary Sensory Neurons | Journal of Neuroscience
SMOC2 Antibodies & ELISA Kits, SMOC-2 Proteins
JCI Insight - Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation
SMOC2 Gene - GeneCards | SMOC2 Protein | SMOC2 Antibody
SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers | Scientific Reports
SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers | Scientific Reports
Smoc1 and Smoc2 regulate bone formation as downstream molecules of Runx2 | Communications Biology
Fibroblastic SMOC2 Suppresses Mechanical Nociception by Inhibiting Coupled Activation of Primary Sensory Neurons | Journal of Neuroscience
SMOC2 Antibody (ABIN1501005)
TGF-β1/SMOC2/AKT and ERK axis regulates proliferation, migration, and fibroblast to myofibroblast transformation in lung fibroblast, contributing with the asthma progression | Hereditas | Full Text
SMOC2 promotes an epithelial-mesenchymal transition and a pro-metastatic phenotype in epithelial cells of renal cell carcinoma origin | Cell Death & Disease
SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers | Scientific Reports